Faculty of Medicine

Academic Members

Prof. Mehmet Özen

Prof.
Mehmet Özen

Hematoloji (İç Hastalıkları)

I was born in 1982 in Çorum Mecitözü. I graduated from Hacettepe University Faculty of Medicine in 2005. I received the title of Internal Medicine Specialist from Hacettepe University in 2010 and the title of Hematology Specialist from Ankara University in 2014. I received the title of Lecturer in 2016 and Associate Professor of Internal Medicine (Hematology) in 2017. In 2007, I received intensive care training at Gainesville University in Florida, USA, and flow cytometry training at Salamanca University in Spain in 2014. I have more than 30 articles published in national and international journals, and more than 100 notifications in national and international congresses. These publications have received more than 100 citations. I also have 1 patent. Since 2010, I have been interested in the treatment of hematological cancers such as leukemia, lymphoma and myeloma. Since then, I have participated in teams that perform allogeneic, autologous, haploidentic and mesenchymal stem cell treatments and applied stem cell therapy to hundreds of patients. Since 2022, I have been working as a physician in charge in the hematology and bone marrow transplant unit of Istinye University Gaziosmanpaşa Medical Park Hospital.

Araştırma Alanları

  • Hematological Cancers, Leukemia, Lymphoma, Myeloma, Bone Marrow Transplantation, autologous, allogeneic, haploidentic and mesenchymal stem cell therapies

Çalışma Alanları

  • Sağlık Bilimleri Temel Alanı
  • Hematoloji (İç Hastalıkları)
  • The effect of age on peripheral stem cell mobilization in healthy donors single center experience, 2017
  • Trastuzumab 1 Year vs 9 Week in Early Stage Her2 Positive Lymph Node Negative Breast Cancer Patients, 2016
  • A Quasi Experimental Study Analyzing the Effectiveness of Portable High Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction, 2016
  • Editöre mektup, 2016
  • Therapeutic Plasma Exchange Ameliorates Incompatible Crossmatchs, 2016
  • Evaluation of Candida Species and Risk Factors in Haematologic Cancer Patients With Candidemia, 2015
  • Splenic Malignant Lesions in Lymphoma and Solid Tumors A Comparative Study of Imaging Techniques, 2015
  • Antilymphocyte Thymocyte Globulin for the Treatment of Steroid Refractory Acute Graft Versus Host Disease 20 Year Experience at a Single Center, 2015
  • Autoimmune disease tumor necrosis factor inhibitors and acute leukemia possible associations in two patients, 2014
  • As a Rare Presentation of Waldenstrom s Macroglobulinemia Fever, 2014
  • How confocal laser endomicroscopy can help us in diagnosing gastric lymphomas, 2012
  • Lung Cancer in Young Patients Under the Age of Thirty five Single Center Experience, 2012
  • SAPHO syndrome may be treated effectively with combined drug regimens A case report, 2011
  • Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER 2 overexpression, 2007
  • Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer s disease, 2007
  • Bisphosphonates may also be effective in the management of non skeletal metastases in hormone receptor positive breast cancer, 2007
  • Tooth extraction Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates, 2007
  • Allogeneic Transplantation In Chronic Myeloid Leukemia And The Effect Of Tyrosine Kinase Inhibitors On Survival A Quasi Experimental Study,
  • THE APPLICATION OF SECOND TIME ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION REASONS AND OUTCOME, 2014
  • RISK FACTORS FOR THE DEVELOPMENT OF INVASIVE FUNGAL INFECTION IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2014
  • Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation, 2014
  • The outcome of allogeneic haematopoetic stem cell transplantation in adult patients older than 50 years, 2013
  • Comparison Of Flow Cytometric and Clinical Findings In Patients With Paroxysmal Nocturnal Hemoglobinuria, 2013
  • Comparison of allogeneic stem cell transplantations in chronic myeloid leukemia before and after the era of tyrosine kinase inhibitors, 2013
  • Hepa systems in hematology clinic to ameliorate the increased fungal infection risk owing to environmental changing, 2013
  • Tumor necrosis factor inhibitors and acute leukemia in two cases, 2013
  • Impact of PET CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma Comparison of Two Cut Off Values, 2014
  • Is R CODOX M IVAC Inferior to Other Regimens in Burkitt s Lymphoma A Single Center Experience, 2014
  • The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph Acute Lymphoblastic Leukemia, 2014
  • A FOURIER TRANSFORM INFRARED SPECTROSCOPIC INVESTIGATIONS ON THE MOLECULAR PROFILING OF MULTIPLE MYELOMA, 2012
  • Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2 positive breast cancer patients Retrospective analysis, 2010
  • ANTI THYMOCYTE GLOBULINE ATG or ANTI LYMPHOCYTE GLOBULINE ALG for TREATMENT of STEROID REFRACTORY ACUTE GRAFT versus HOST DISEASE GvHD, 2015
  • Clinical Features and Treatment of Splenic Marginal zone lymphoma, 2013
  • Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation, 2014
  • Do FMS like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia, 2014
  • The relapse in acute leukemia after the allogeneic hematopoietic stem cell transplantation No approaches have been superior yet, 2015
  • Upgrade Of FDG PET Response Following Autologous Stem Cell Transplantation Is Associated With Better Progression Free Survival Among Patients With Multiple Myeloma, 2015
  • İNŞAAT SIRASINDA MEYDANA GELEBİLECEK HEMATOLOJİK İNFEKSİYONLARIN ENGELLENMESİ, 2014
  • R CODOX M IVAC Burkitt Lenfoma da Diğer Tedavi Rejimlerinden Gerçekten Üstün Mü Tek Merkez Deneyimi, 2014
  • Erken Evre Her2 pozitif Meme Kanserli Hastalarda Adjuvan Kemoterapiye 9 Haftalık Trastuzumab Eklenmesi Retrospektif Değerlendirme, 2010
  • Elmasın Ağır Yüzü Ağır Metale Bağlı Meslek Hastalığı Olarak Elmas Taşlama, 2010
  • Pronator Sendromu ve Sistemik Lupus Eritematozis İlk Kez Birlikte Görüldüler, 2010
  • Preoperatif Değerlendirmede Prolidaz Eksikliği Erişkinin Doktoru Ne Yapmalı, 2010
  • ANTİ TÜMÖR NEKROZİS FAKTÖR ANTİ TNF VE AZATİOPÜRİN TEDAVİSİ ALAN İKİ OLGUDA AKUT LÖSEMİ GELİŞİMİ, 2012
  • ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ SONRASI KRONİK MİYELOSİTER LÖSEMİDE TİROZİN KİNAZ İNHİBİTÖRLERİNE DUYARLILIK İKİ OLGU SUNUSU, 2012
  • Kök Hücre Nakil Ünitesinde H1N1 Epidemisi ve Kontrolü, 2013
  • Bir hematoloji kliniğinde yedi yıllık dönemde kan kültürlerinden izole edilen candida türleri, 2013
  • Hematoloji kliniğinde bir yılda gelişen hastane infeksiyonları, 2013
  • İZOLE KEMİK TUTULUMU İLE GİDEN SAÇLI HÜCRELİ LÖSEMİ BİR OLGU SUNUMU, 2013
  • ALLOJENEİK HEMATOPOİETİK KÖK HÜCRE NAKLİ SONRASI HEMORAJİK SİSTİT GELİŞİMİ VE YAKLAŞIMI, 2013
  • AKUT BAŞLANGIÇLI BİR KRONİK MYELOPROLİFERATİF HASTALIK VAKA RAPORU, 2013
  • AKRABA DIŞI NAKİLLERDE YENİDEN SAYIMIN ÖNEMİ, 2013
  • NADİR BİR VAKA OLARAK BLASTİK PLAZMASİTOİD DENDRİTİK HÜCRELİ LÖSEMİ, 2013
  • İKİNCİ KEZ ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ UYGULANMASI NEDENLERİ VE SONUÇLARI, 2014
  • DİRENÇLİ HEMORAJİK SİSTİT İN TEDAVİSİNDE VEZİKAL ARTER EMBOLİZASYONU BİR OLGU SUNUMU, 2014
  • AKRABA DIŞI ALLOJENEİK HEMATOPOETİK HÜCRE NAKLİNDE HLA UYUŞUMUNUN ETKİSİ TEK MERKEZ DENEYİMİ, 2014
  • İshal Sonrası Gelişen Trombotik Trombositopenik Purpura Olgu Sunumu, 2015
  • Fark edilmemiş Diyabet Nelere Yol Açabilir Diyabete Sekonder Gelişen Hipertrigliseritemiye Bağlı Akut Pankreatit ve Plazmaferez ile Tedavisi, 2015
  • Amitriptilin Zehirlenmesinde Terapötik Plazma Değişimi, 2015
  • Erişkin akut lenfoblastik lösemi hastalarında hücre alt tipinin hypercvad ile indüksiyona yanıtlara etkisinin araştırılması, 2015
  • Dirençli Hodgkin Lenfomalı Hastada MTOR İnhibitörü Sirolimus ve Histon Deasetilaz HDAC İnhibitörü Vorinostat Aktivitesi, 2014
  • Sağlıklı Vericilerde İleri Yaşın Çevre Kanı Kök Hücre Mobilizasyonuna Etkisi, 2014
  • Hematolojik kanserli hastalarda bakteriyemi etkenleri ve kinolon direnci, 2011
  • Ülkemizde İmmün Trombositopenide Eltrombopag Kullanımı, 2015
  • 40 yas altı akut lenfoblastik lösemi hastalarında dana farber ve hypercvad protokollerinin karşılaştırılması, 2015
  • Proteozom İnhibitörü ve İmmünmodülatör İlaçlara Direnç Geliştirmiş Multiple Myelom Hastalarında Bendamustin İçeren Tedavi Sonuçlarımız, 2014
  • Multipl Myelom Tanılı Olgularda OPKHN Sonrası Klinik Yanıt İle PET Yanıtının Yaşam Göstergelerine Etkisi İki Farklı Eşik Değerinin Karşılaştırma Sonuçları, 2015
  • FMS Benzeri Tirozin Kinaz 3 ve Nükleofosmin 1 Gen Mutasyonlarının Akut Myeloid Lösemide Sağkalıma Etkisi, 2014
  • Akut Lösemilerde Transplantasyon Sonrası Nükste Yaklaşımlar, 2014
  • ALLOJENEİK HEMATOPOİETİK KÖK HÜCRE NAKLİ ALLO HKHN YAPILAN HASTALARDA FUNGAL VE SİTOMEGALOVİRÜS CMV ENFEKSİYON GELİŞİMİNDE RİSK FAKTÖRLERİ, 2013
  • DEĞİŞEN ÇEVRE ORTAMINDAKİ HEMATOLOJİ HASTALARINDA ENFEKSİYONLARIN ÖNLENMESİNDE YÜKSEK ETKİNLİKTE PARTİKÜL YAKALAYICI SİSTEM UYGULAMASI VE ANTİFUNGAL PROFİLAKSİNİN ETKİNLİĞİ, 2012
  • TİROZİN KİNAZ İNHİBİTÖRÜ ÇAĞI ÖNCESİ TKİÖ VE SONRASI TKİS KML DE ALLOJENEİK KÖK HÜCRE NAKİLLERİNİN KARŞILAŞTIRMALI DEĞERLENDİRİLMESİ, 2012
  • Genç 35 yaş Akciğer Kanserli Hastaların Retrospektif Analizi, 2010
  • LDL APHERESIS THE COMPARISON OF TWO DEVICES, 2014
  • MD Anderson Tıbbi Onkoloji, ISBN: 9786053350088, 2013
  • MD Anderson Tıbbi Onkoloji, ISBN: 9786053350088, 2013
  • MD Anderson Tıbbi Onkoloji, ISBN: 9786053350088, 2013
  • Klinik Olgu Çözümleri Hematoloji, ISBN: 9786053971207, 2011
  • YILIN HEKİMİ, 2014
  • Şeref Zileli Yılın Başarılı Asistanı Ödülü, 2009